Quanterix Q4 rev +35% non-GAAP, CEO Hrusovsky becomes Exec Chair, Toloue CEO, Lilly deal $11M

Quanterix Corp

Q4 GAAP total revenue $30.3M (+16% YoY); non-GAAP total revenue $29.3M (+35% YoY).
FY 2021 GAAP total revenue $110.6M (+28% YoY); product revenue $81.1M (+84% YoY).
CEO Kevin Hrusovsky becomes Executive Chairman; President Masoud Toloue succeeds as CEO and joins Board, effective April 25, 2022.
Collaboration with Eli Lilly: non-exclusive license to P-tau217 antibody technology; Lilly funds $11M development this year.

item 2.02 item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Kevin Hrusovsky

Executive Chairman

QTRX · Quanterix Corp

Effective: 2022-04-25
Successor: Masoud Toloue
Filed: March 1, 2022, 6:59 PM ET

Effective April 25, 2022, Chairman and Chief Executive Officer Kevin Hrusovsky will become Executive Chairman of the Board of Directors, and President of Quanterix and Diagnostics Masoud Toloue will succeed Mr. Hrusovsky as Chief Executive Officer and join Quanterix’ Board of Directors.

Appointed

Masoud Toloue

Chief Executive Officer

QTRX · Quanterix Corp

Effective: 2022-04-25
Filed: March 1, 2022, 6:59 PM ET

and President of Quanterix and Diagnostics Masoud Toloue will succeed Mr. Hrusovsky as Chief Executive Officer and join Quanterix’ Board of Directors.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Kevin Hrusovsky changed role as Executive Chairman at Quanterix Corp.

Action: become
Role: Executive Chairman

Exact text from the filing

Effective April 25, 2022, Chairman and Chief Executive Officer Kevin Hrusovsky will become Executive Chairman of the Board of Directors, and President of Quanterix and Diagnostics Masoud Toloue will succeed Mr. Hrusovsky as Chief Executive Officer and join Quanterix’ Board of Directors.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

Masoud Toloue was appointed as Chief Executive Officer at Quanterix Corp.

Action: succeed
Role: Chief Executive Officer

Exact text from the filing

and President of Quanterix and Diagnostics Masoud Toloue will succeed Mr. Hrusovsky as Chief Executive Officer and join Quanterix’ Board of Directors.

View on SEC.gov

Quanterix Corp filing history →

Source: SEC EDGAR

accession 0001104659-22-028337

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.